Patents by Inventor Philip Dormitzer

Philip Dormitzer has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • RSV immunization regimen
    Patent number: 11813323
    Abstract: The invention relates to an immunization regimen whereby an infant is protected against respiratory syncytial virus (RSV) through administration of a first anti-RSV immune response inducing composition to his or her mother during pregnancy, followed by administration of a second anti-RSV immune response inducing composition to the infant after birth.
    Type: Grant
    Filed: June 24, 2022
    Date of Patent: November 14, 2023
    Assignee: GLAXOSMITHKLINE BIOLOGICALS SA
    Inventor: Philip Dormitzer
  • RSV IMMUNIZATION REGIMEN
    Publication number: 20230072995
    Abstract: The invention relates to an immunization regimen whereby an infant is protected against respiratory syncytial virus (RSV) through administration of a first anti-RSV immune response inducing composition to his or her mother during pregnancy, followed by administration of a second anti-RSV immune response inducing composition to the infant after birth.
    Type: Application
    Filed: June 24, 2022
    Publication date: March 9, 2023
    Applicant: GLAXOSMITHKLINE BIOLOGICALS SA
    Inventor: Philip DORMITZER
  • RSV immunization regimen
    Patent number: 11452773
    Abstract: The invention relates to an immunization regimen whereby an infant is protected against respiratory syncytial virus (RSV) through administration of a first anti-RSV immune response inducing composition to his or her mother during pregnancy, followed by administration of a second anti-RSV immune response inducing composition to the infant after birth.
    Type: Grant
    Filed: May 28, 2019
    Date of Patent: September 27, 2022
    Assignee: GLAXOSMITHKLINE BIOLOGICALS SA
    Inventor: Philip Dormitzer
  • Antigenically matched influenza vaccines
    Patent number: 11013795
    Abstract: Disclosed herein are influenza vaccine compositions, related preparations and intermediates, formulations, production methods, immunization methods, and use thereof, for achieving improved immune-protection in human subjects. More specifically, non-egg-based influenza vaccines are described, which provide improved antigenic match.
    Type: Grant
    Filed: June 24, 2016
    Date of Patent: May 25, 2021
    Assignee: Seqirus UK Limited
    Inventors: Ethan Settembre, Philip Dormitzer
  • Influenza virus reassortment
    Patent number: 10864264
    Abstract: New influenza donor strains for the production of reassortant influenza B viruses are provided.
    Type: Grant
    Filed: October 18, 2019
    Date of Patent: December 15, 2020
    Assignees: Seqirus UK Limited, Synthetic Genomics, Inc.
    Inventors: Philip Dormitzer, Peter Mason, Pirada Suphaphiphat, Raul Gomila
  • INFLUENZA VIRUS REASSORTMENT
    Publication number: 20200215184
    Abstract: New influenza donor strains for the production of reassortant influenza B viruses are provided.
    Type: Application
    Filed: October 18, 2019
    Publication date: July 9, 2020
    Applicants: Seqirus UK Limited, Synthetic Genomics, Inc.
    Inventors: Philip DORMITZER, Peter MASON, Pirada SUPHAPHIPHAT, Raul GOMILA
  • INFLUENZA VIRUS REASSORTMENT
    Publication number: 20200172877
    Abstract: Improved methods for the production of reassortant influenza viruses are provided.
    Type: Application
    Filed: September 26, 2019
    Publication date: June 4, 2020
    Applicants: Seqirus UK Limited, Synthetic Genomics, Inc.
    Inventors: Philip DORMITZER, Peter MASON, Pirada SUPHAPHIPHAT, Daniel GIBSON, David WENTWORTH, Timothy STOCKWELL, John GLASS
  • Reverse genetics systems
    Patent number: 10610584
    Abstract: The invention provides various reverse genetics systems for producing segmented RNA viruses, wherein the systems do not require bacteria for propagation of all of their expression constructs.
    Type: Grant
    Filed: October 16, 2017
    Date of Patent: April 7, 2020
    Assignee: Seqirus UK Limited
    Inventors: Philip Dormitzer, Michael Franti, Peter Mason
  • INFLUENZA VIRUS REASSORTMENT
    Publication number: 20200000909
    Abstract: New influenza donor strains for the production of reassortant influenza A viruses are provided.
    Type: Application
    Filed: February 11, 2019
    Publication date: January 2, 2020
    Applicant: Seqirus UK Limited
    Inventors: Pirada SUPHAPHIPHAT, Peter MASON, Bjoern KEINER, Philip DORMITZER, Heidi TRUSHEIM
  • REVERSE GENETICS USING NON-ENDOGENOUS POL I PROMOTERS
    Publication number: 20190284575
    Abstract: Expression of a transgene is driven in a host cell using a pol I promoter which is not endogenous to an organism from the same taxonomic order from which the host cell is derived.
    Type: Application
    Filed: January 30, 2019
    Publication date: September 19, 2019
    Inventors: Philip Dormitzer, Michael Franti, Pirada Suphaphiphat, Peter Mason, Bjoern Keiner, Stefania Crotta
  • RSV IMMUNIZATION REGIMEN
    Publication number: 20190275141
    Abstract: The invention relates to an immunization regimen whereby an infant is protected against respiratory syncytial virus (RSV) through administration of a first anti-RSV immune response inducing composition to his or her mother during pregnancy, followed by administration of a second anti-RSV immune response inducing composition to the infant after birth.
    Type: Application
    Filed: May 28, 2019
    Publication date: September 12, 2019
    Applicant: GLAXOSMITHKLINE BIOLOGICALS S.A.
    Inventor: Philip DORMITZER
  • Influenza virus reassortment
    Patent number: 10329537
    Abstract: The invention provides reassortant influenza strains.
    Type: Grant
    Filed: June 6, 2014
    Date of Patent: June 25, 2019
    Assignees: Seqirus UK Limited, Synthetic Genomics, Inc.
    Inventors: Peter Mason, Pirada Suphaphiphat, Raul Gomila, Philip Dormitzer
  • Influenza virus reassortment
    Patent number: 10245312
    Abstract: New influenza donor strains for the production of reassortant influenza A viruses are provided.
    Type: Grant
    Filed: July 14, 2016
    Date of Patent: April 2, 2019
    Assignee: Seqirus UK Limited
    Inventors: Pirada Suphaphiphat, Peter Mason, Bjoern Keiner, Philip Dormitzer, Heidi Trusheim
  • Influenza virus reassortment
    Patent number: 10232031
    Abstract: New influenza donor strains for the production of reassortant influenza B viruses are provided.
    Type: Grant
    Filed: March 13, 2014
    Date of Patent: March 19, 2019
    Assignees: Seqirus UK Limited, Synthetic Genomics, Inc.
    Inventors: Philip Dormitzer, Peter Mason, Pirada Suphaphiphat, Raul Gomila
  • REVERSE GENETICS SYSTEMS
    Publication number: 20180236058
    Abstract: The invention provides various reverse genetics systems for producing segmented RNA viruses, wherein the systems do not require bacteria for propagation of all of their expression constructs.
    Type: Application
    Filed: October 16, 2017
    Publication date: August 23, 2018
    Inventors: Philip DORMITZER, Michael Franti, Peter Mason
  • Influenza virus reassortment
    Patent number: 10030231
    Abstract: Improved methods for the production of reassortant influenza viruses are provided.
    Type: Grant
    Filed: January 23, 2014
    Date of Patent: July 24, 2018
    Assignees: Seqirus UK Limited, Synthetic Genomics Vaccines, Inc.
    Inventors: Philip Dormitzer, Peter Mason, Pirada Suphaphiphat, Daniel Gibson, David Wentworth, Timothy Stockwell, John Glass
  • ANTIGENICALLY MATCHED INFLUENZA VACCINES
    Publication number: 20180177862
    Abstract: Disclosed herein are influenza vaccine compositions, related preparations and intermediates, formulations, production methods, immunization methods, and use thereof, for achieving improved immune-protection in human subjects. More specifically, non-egg-based influenza vaccines are described, which provide improved antigenic match.
    Type: Application
    Filed: June 24, 2016
    Publication date: June 28, 2018
    Inventors: Ethan SETTEMBRE, Philip DORMITZER
  • Reverse genetics systems
    Patent number: 9821052
    Abstract: The invention provides various reverse genetics systems for producing segmented RNA viruses, wherein the systems do not require bacteria for propagation of all of their expression constructs.
    Type: Grant
    Filed: July 30, 2010
    Date of Patent: November 21, 2017
    Assignee: Seqirus UK Limited
    Inventors: Philip Dormitzer, Michael Franti, Peter Mason
  • IMMUNIZATION PROTOCOL FOR DIRECTED EXPANSION AND MATURATION
    Publication number: 20170189502
    Abstract: A first antigen is administered to a subject to select progenitor B cells that are suitable for subsequent production of a desirable affinity-matured antibody, and then a second antigen is administered to stimulate the expansion of B cells that produce that affinity-matured antibody. An immunization protocol is used in which two different antigens are administered (usually in series, but in some embodiment simultaneously), where the first antigen elicits an efficient germline antibody response and the second antigen elicits an efficient and desired affinity-matured antibody response.
    Type: Application
    Filed: December 14, 2016
    Publication date: July 6, 2017
    Inventor: Philip Dormitzer
  • INFLUENZA VIRUS REASSORTMENT
    Publication number: 20170095549
    Abstract: New influenza donor strains for the production of reassortant influenza A viruses are provided.
    Type: Application
    Filed: July 14, 2016
    Publication date: April 6, 2017
    Inventors: Pirada SUPHAPHIPHAT, Peter MASON, Bjoern KEINER, Philip DORMITZER, Heidi TRUSHEIM